|
 |
Diabetes > Peptide
The following information is about Peptide.
Peptide Defined
Two or more amino acids linked together chemically. If the number of amino acids is relatively great, the string is sometimes called a polypeptide; a very long string of amino acids is called a protein.
This definition is in context to Diabetes. See more contextual defintions for Peptide.
New Once-a-week Treatment For Type 2 Diabetes Developed
Published September 7, 2008, 7:15 pm, Science Daily
Researchers have reported that a new once-weekly treatment for type 2 diabetes could replace the more common twice-daily injection.
New once-a-week treatment for type 2 diabetes developed by Mount Sinai researcher
Published September 7, 2008, 4:15 pm, EurekAlert!
( Samuel Lunenfeld Research Institute ) In a study published by the Lancet journal today, Toronto researcher Dr. Daniel Drucker reported that a new once-weekly treatment for type 2 diabetes could replace the more common twice-daily injection.
Rasilez(R), First-In-Class Direct Renin Inhibitor, Lowers High Blood Pressure More Effectively Than Diuretic In Obese ...
Published September 7, 2008, 3:17 am, Medical News Today
New clinical data analysis confirms that the first-in-class direct renin inhibitor Rasilez® (aliskiren), known as Tekturna® in the US, provides significantly greater blood pressure reductions in obese patients with high blood pressure compared to the diuretic hydrochlorothiazide (HCT) alone1.
BioMS Medical's dirucotide receives fast track designation
Published September 6, 2008, 1:39 am, PharmaBiz
BioMS Medical Corp, a leading developer in the treatment of multiple sclerosis (MS), announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for the company's lead drug, dirucotide (MBP8298), for the treatment of secondary progressive MS (SPMS). Dirucotide (MBP8298) is currently being evaluated in a US pivotal phase-III trial, named ...
Rasilez lowers BP in obese patients
Published September 6, 2008, 12:39 am, PharmaBiz
New clinical data analysis confirms that the first-in-class direct renin inhibitor Rasilez (aliskiren), known as Tekturna in the US, provides significantly greater blood pressure reductions in obese patients with high blood pressure compared to the diuretic hydrochlorothiazide (HCT) alone.
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
Published September 5, 2008, 6:45 am, PR Newswire via Yahoo! Finance
CEL-SCI Corporation announced today that it presented new rheumatoid arthritis data at the Marcus Evans conference on Immunogenicity in Amsterdam.
FDA 'fast track' granted to BioMS Medical for lead drug, dirucotide for the treatment of multiple sclerosis
Published September 4, 2008, 6:10 am, News-Medical-Net
BioMS Medical Corp has announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for the Company's lead drug, dirucotide (MBP8298), for the treatment of secondary progressive MS (SPMS). Dirucotide (MBP8298) is currently being evaluated in a U.S. pivotal phase III trial, named MAESTRO-03, at 68 sites with approximately 510 patients.
MDRNA Receives Additional Funding from National Institutes of Health
Published September 4, 2008, 5:55 am, Centre Daily Times
MDRNA, Inc. (Nasdaq: MRNA) announced today that the National Institutes of Health (NIH) has awarded the Company over $350,000 for further development of the Company's siRNA therapeutics program to prevent and treat influenza. These funds are part of a five-year grant totaling $1.9 million that the NIH awarded the Company in September 2006 to study the underlying scientific principles that enable ...
BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track ...
Published September 4, 2008, 5:00 am, CNW Group via Yahoo! Finance
BioMS Medical Corp. , a leading developer in the treatment of multiple sclerosis , today announced that the Food and Drug Administration of the United States has granted fast track designation for the Company's lead drug, dirucotide , for the treatment of secondary progressive MS .
MDRNA Receives Additional Funding from National Institutes of Health
Published September 4, 2008, 5:00 am, Business Wire via Yahoo! Finance
BOTHELL, Wash.----MDRNA, Inc. announced today that the National Institutes of Health has awarded the Company over $350,000 for further development of the Company's siRNA therapeutics program to prevent and treat influenza.
Are you looking for additional Diabetes > Peptide news? Try our new "Peptide News Focus" area.
Off-site Peptide Links, User Submitted
The following links have been collected through user bookmark submission in the Peptide category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Tue Sep 2
- NCBI Sequence Viewer v2.0
- Ensembl release 50: Danio rerio Gene report for ENSDARG0000004 3460
- Ensembl release 50: Danio rerio Gene report for ENSDARG0000005 2948
Fri Aug 22
Thu Aug 21
Wed Aug 13
Fri Aug 1
Mon Jul 28
Sun Jul 27
- peptide: peptide
Fri Jul 25
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Peptide. If you would like to find related tags we recommend Tag Patterns > Peptide
Off-site Peptide Research Links
If you still need additional information on Peptide then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Diabetes Topics
Everything you need to know about Diabetes
Diabetes
If you know the Diabetes Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Diabetes.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.